186PPhase II trial of tepotinib vs sorafenib for treatment-naïve advanced hepatocellular carcinoma (HCC) in Asian patients. (25th November 2018) - Ryoo, B-Y; Ren, Z; Kim, T-Y; Pan, H; Rau, K-M; Choi, H J; Park, J-W; Kim, J H; Yen, C-J; Kim, B-H; Zhou, D; Straub, J; et al.